These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 33705736)

  • 1. Development of a long-term, IL7 dependent cell death rescue assay in CD4+ T-cells.
    Perez-Witzke D; Parmar R; Blancq I; Turpin MA; Ponchel F
    J Immunol Methods; 2021 Jun; 493():113020. PubMed ID: 33705736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 7 stimulates tumour necrosis factor alpha and Th1 cytokine production in joints of patients with rheumatoid arthritis.
    van Roon JA; Glaudemans KA; Bijlsma JW; Lafeber FP
    Ann Rheum Dis; 2003 Feb; 62(2):113-9. PubMed ID: 12525379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL7 increases targeted lipid nanoparticle-mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation.
    Tilsed CM; Sadiq BA; Papp TE; Areesawangkit P; Kimura K; Noguera-Ortega E; Scholler J; Cerda N; Aghajanian H; Bot A; Mui B; Tam Y; Weissman D; June CH; Albelda SM; Parhiz H
    Proc Natl Acad Sci U S A; 2024 Mar; 121(13):e2319856121. PubMed ID: 38513098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-7 improves reconstitution of antiviral CD4 T cells.
    Lu H; Zhao Z; Kalina T; Gillespy T; Liggitt D; Andrews RG; Maloney DG; Kiem HP; Storek J
    Clin Immunol; 2005 Jan; 114(1):30-41. PubMed ID: 15596407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of interleukin 7 activity and levels on tumour necrosis factor alpha blockade in patients with rheumatoid arthritis.
    van Roon JA; Hartgring SA; Wenting-van Wijk M; Jacobs KM; Tak PP; Bijlsma JW; Lafeber FP
    Ann Rheum Dis; 2007 May; 66(5):664-9. PubMed ID: 17185327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravaginal Administration of Fc-Fused IL7 Suppresses the Cervicovaginal Tumor by Recruiting HPV DNA Vaccine-Induced CD8 T Cells.
    Choi YW; Kang MC; Seo YB; Namkoong H; Park Y; Choi DH; Suh YS; Lee SW; Sung YC; Jin HT
    Clin Cancer Res; 2016 Dec; 22(23):5898-5908. PubMed ID: 27407095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 7 enhances the proliferation and effector function of tumor-infiltrating lymphocytes from renal-cell carcinoma.
    Sica D; Rayman P; Stanley J; Edinger M; Tubbs RR; Klein E; Bukowski R; Finke JH
    Int J Cancer; 1993 Apr; 53(6):941-7. PubMed ID: 8473051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effector CD8+ T-cell Engraftment and Antitumor Immunity in Lymphodepleted Hosts Is IL7Rα Dependent.
    Johnson CB; Riesenberg BP; May BR; Gilreath SC; Li G; Staveley-O'Carroll KF; Garrett-Mayer E; Mehrotra S; Cole DJ; Rubinstein MP
    Cancer Immunol Res; 2015 Dec; 3(12):1364-74. PubMed ID: 26297711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine signals in T-cell homeostasis.
    Guimond M; Fry TJ; Mackall CL
    J Immunother; 2005; 28(4):289-94. PubMed ID: 16000945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CD2 and CD28 adhesion molecules induce long-term autocrine proliferation of CD4+ T cells.
    Costello R; Cerdan C; Pavon C; Brailly H; Hurpin C; Mawas C; Olive D
    Eur J Immunol; 1993 Mar; 23(3):608-13. PubMed ID: 8095456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-7/STAT5 cytokine signaling pathway is essential but insufficient for maintenance of naive CD4 T cell survival in peripheral lymphoid organs.
    Seki Y; Yang J; Okamoto M; Tanaka S; Goitsuka R; Farrar MA; Kubo M
    J Immunol; 2007 Jan; 178(1):262-70. PubMed ID: 17182563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-7 signalling is sufficient to phenotypically and functionally prime human CD4 naive T cells.
    Managlia EZ; Landay A; Al-Harthi L
    Immunology; 2005 Mar; 114(3):322-35. PubMed ID: 15720434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination immunotherapy with clinical-scale enriched human gammadelta T cells, hu14.18 antibody, and the immunocytokine Fc-IL7 in disseminated neuroblastoma.
    Otto M; Barfield RC; Martin WJ; Iyengar R; Leung W; Leimig T; Chaleff S; Gillies SD; Handgretinger R
    Clin Cancer Res; 2005 Dec; 11(23):8486-91. PubMed ID: 16322312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL7 receptor signaling in T cells: A mathematical modeling perspective.
    Park JH; Waickman AT; Reynolds J; Castro M; Molina-París C
    Wiley Interdiscip Rev Syst Biol Med; 2019 Sep; 11(5):e1447. PubMed ID: 31137085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NF-kappa B cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes.
    Khoshnan A; Tindell C; Laux I; Bae D; Bennett B; Nel AE
    J Immunol; 2000 Aug; 165(4):1743-54. PubMed ID: 10925251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo evaluation of the effects of interleukins 2, 4 and 7 on enhancing the immunotherapeutic efficacy of anti-tumor cytotoxic T lymphocytes.
    Lynch DH; Namen AE; Miller RE
    Eur J Immunol; 1991 Dec; 21(12):2977-85. PubMed ID: 1684156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-α inhibits CD4 T cell responses to interleukin-7 and interleukin-2 and selectively interferes with Akt signaling.
    Nguyen TP; Bazdar DA; Mudd JC; Lederman MM; Harding CV; Hardy GA; Sieg SF
    J Leukoc Biol; 2015 Jun; 97(6):1139-46. PubMed ID: 25784743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation.
    Abe R; Vandenberghe P; Craighead N; Smoot DS; Lee KP; June CH
    J Immunol; 1995 Feb; 154(3):985-97. PubMed ID: 7822814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD28 ligands CD80 (B7-1) and CD86 (B7-2) induce long-term autocrine growth of CD4+ T cells and induce similar patterns of cytokine secretion in vitro.
    Levine BL; Ueda Y; Craighead N; Huang ML; June CH
    Int Immunol; 1995 Jun; 7(6):891-904. PubMed ID: 7577797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.